Talk to Us

Blue Cross Blue Shield Oklahoma policies, page 3

Search Blue Cross Blue Shield Oklahoma's public medical, payment and drug policies by CPT or HCPCS code, keyword or policy number, with links to the payer's own documents. Links open the payer's own document; check its current version before relying on it.

534 public policies Substrate tracks for Blue Cross Blue Shield Oklahoma, by title.

Blue Cross Blue Shield Oklahoma policies
PolicyDetailsCodesSource
Coronavirus Testing in the Outpatient SettingCPCPLAB057 · Effective Nov 7, 2025 · Commercial, Medicaid · OK27Original policy ↗
Coronavirus Testing in the Outpatient SettingRPLAB057 · Effective Dec 4, 2026 · Commercial, Medicaid · OK27Original policy ↗
Corrected Claim SubmissionsCPCP025 · Effective Dec 1, 2025 · Commercial, Medicaid · OK—Original policy ↗
Cosmetic and Reconstructive ProceduresSUR716.001 · Commercial, Medicaid62Original policy ↗
Cranial Electrotherapy Stimulation and Auricular ElectrostimulationSUR702.019 · Effective Sep 1, 2026 · Commercial, Medicaid11Original policy ↗
Crizanlizumab-tmcaRX501.126 · Commercial, Medicaid1Original policy ↗
Crovalimab-akkzRX501.176 · Commercial, Medicaid1Original policy ↗
Cryoablation of Tumors Located in the Kidney, Lung, Breast, Pancreas, or BoneSUR701.018 · Effective Jan 1, 2026 · Commercial, Medicaid11Original policy ↗
Cryoablation, Radiofrequency Ablation, and Laser Ablation for Treatment of Chronic RhinitisSUR706.020 · Effective Jun 15, 2025 · Commercial, Medicaid6Original policy ↗
Cryosurgical Ablation of Primary or Metastatic Liver TumorsSUR701.032 · Commercial, Medicaid5Original policy ↗
Custodial CareADM1001.014 · Commercial, Medicaid13Original policy ↗
Decompression of the Intervertebral Disc Using Laser Energy (Laser Discectomy) or Radiofrequency Coblation (Nucleoplasty)SUR712.037 · Effective Nov 15, 2025 · Commercial, Medicaid3Original policy ↗
Deep Brain StimulationSUR712.025 · Effective Sep 15, 2026 · Commercial, Medicaid17Original policy ↗
Delandistrogene moxeparvovec-roklRX501.163 · Effective Jan 1, 2026 · Commercial, Medicaid1Original policy ↗
Denosumab and Biosimilars for Non-Oncologic IndicationsRX501.140 · Commercial, Medicaid14Original policy ↗
Depemokimab-ulaaRX501.192 · Effective Sep 1, 2026 · Commercial, Medicaid1Original policy ↗
Dermatologic Applications of Photodynamic TherapyTHE801.027 · Commercial, Medicaid6Original policy ↗
Device Therapies for Gastroesophageal Reflux Disease (GERD)MED201.016 · Effective Jan 1, 2026 · Commercial, Medicaid10Original policy ↗
Diabetes Mellitus TestingCPCPLAB004 · Effective Jan 3, 2026 · Commercial, Medicaid · OK6Original policy ↗
Diabetes Mellitus TestingRPLAB004 · Effective Dec 4, 2026 · Commercial, Medicaid · OK7Original policy ↗
Diagnosis and Treatment of Chronic Cerebrospinal Venous Insufficiency in Multiple SclerosisMED202.064 · Commercial, Medicaid6Original policy ↗
Diagnosis of Idiopathic Environmental IntoleranceCPCPLAB023 · Effective May 1, 2026 · Commercial, Medicaid · OK51Original policy ↗
Diagnosis of Obstructive Sleep Apnea SyndromeMED204.005 · Effective Jan 1, 2026 · Commercial, Medicaid14Original policy ↗
Diagnosis of VaginitisRPLAB059 · Effective Sep 4, 2026 · Commercial, Medicaid · OK53Original policy ↗
Diagnostic Testing of Common Sexually Transmitted InfectionsRPLAB051 · Effective Sep 4, 2026 · Commercial, Medicaid · OK81Original policy ↗
Diagnostic Testing of InfluenzaCPCPLAB033 · Effective Jan 3, 2026 · Commercial, Medicaid · OK9Original policy ↗
Diagnostic Testing of Iron Homeostasis & MetabolismCPCPLAB008 · Effective May 1, 2026 · Commercial, Medicaid · OK7Original policy ↗
Digital Health Technologies for Attention Deficit/Hyperactivity DisorderPSY301.022 · Commercial, Medicaid5Original policy ↗
Digital Health Technologies: Diagnostic ApplicationsPSY301.024 · Effective Dec 15, 2025 · Commercial, Medicaid5Original policy ↗
Digital Health Technologies: Therapeutic ApplicationsPSY301.025 · Effective Dec 15, 2025 · Commercial, Medicaid6Original policy ↗
Donanemab-azbtRX501.177 · Commercial, Medicaid1Original policy ↗
Drug Testing in Pain Management and Substance Use Disorder TreatmentMED207.154 · Commercial, Medicaid85Original policy ↗
Drug Testing PolicyCPCP020 · Effective Mar 20, 2026 · Commercial, Medicaid · OK8Original policy ↗
Drug-Coated Urethral Balloon for Obstructive Urinary SymptomsSUR710.026 · Commercial, Medicaid4Original policy ↗
Drug-Eluting Sinus ImplantsSUR706.021 · Effective Jan 1, 2026 · Commercial, Medicaid7Original policy ↗
Dry Needling of Trigger Points for Myofascial PainSUR702.018 · Commercial, Medicaid3Original policy ↗
Durable Medical Equipment (DME) Reference ListDME101.000 · Effective Sep 15, 2026 · Commercial, Medicaid67Original policy ↗
Dynamic PosturographyMED205.026 · Commercial, Medicaid2Original policy ↗
Dynamic Spinal Visualization and Vertebral Motion AnalysisRAD601.046 · Commercial, Medicaid5Original policy ↗
Eculizumab and Associated Biosimilar(s)RX501.066 · Commercial, Medicaid8Original policy ↗
EdaravoneRX501.095 · Commercial, Medicaid1Original policy ↗
Efgartigimod alfa-fcab or Efgartigimod alfa and hyaluronidase-qvfcRX501.141 · Commercial, Medicaid2Original policy ↗
Electrical and Electromagnetic Stimulation for the Treatment of ArthritisMED201.042 · Effective Sep 15, 2026 · Commercial, Medicaid4Original policy ↗
Electrical Bone Growth Stimulation of the Appendicular SkeletonSUR705.044 · Commercial, Medicaid4Original policy ↗
Electrical Stimulation of the Spine as an Adjunct to Spinal Fusion ProceduresSUR705.013 · Commercial, Medicaid4Original policy ↗
Electrostimulation and Electromagnetic Therapy for Treating WoundsMED201.027 · Commercial, Medicaid12Original policy ↗
Elivaldogene autotemcelRX501.149 · Effective Jan 1, 2026 · Commercial, Medicaid1Original policy ↗
Emergency Department Services Evaluation and Management (E/M) Coding – Professional ServicesCPCP042 · Effective Nov 14, 2025 · Commercial, Medicaid · OK5Original policy ↗
Endoscopic Radiofrequency Ablation or Cryoablation for Barrett EsophagusSUR709.033 · Effective Jan 1, 2026 · Commercial, Medicaid3Original policy ↗
Endoscopic Ultrasound-Guided Direct Hepatic Portosystemic Pressure Gradient MeasurementSUR701.043 · Commercial, Medicaid1Original policy ↗

Back to Blue Cross Blue Shield Oklahoma · Blue Cross Blue Shield Oklahoma prior authorization CPT list

Disclaimer

The information provided on this page is for general informational purposes only and does not constitute billing, coding, or reimbursement advice. Nothing on this page should be relied upon as a substitute for clinician assessment, professional billing guidance, or as a definitive statement of any payor's billing requirements or policies.

Payor agreements, fee schedules, and billing policies vary and are subject to change. Before submitting any claims related to maternity care services, including claims affected by the 2027 CPT code revisions, please consult the applicable payor agreements, coverage policies, and billing guidelines to confirm current requirements for their specific payor contracts.

Substrate makes no representation or warranty regarding the accuracy, completeness, or timeliness of the payor-specific information presented here. Providers are solely responsible for ensuring that all claims are submitted in accordance with applicable payor requirements, and Substrate assumes no liability for claim denials, underpayments, or other adverse outcomes arising from reliance on this information.

This website uses cookies to ensure you get the best experience on our website. Learn more